217 related articles for article (PubMed ID: 30157279)
1. Extending the functional characteristics of naturally occurring autoantibodies against β-Amyloid, Prion Protein and α-Synuclein.
Albus A; Gold M; Bach JP; Burg-Roderfeld M; Jördens M; Kirchhein Y; Kronimus Y; Mengel D; Zerr I; Dodel R
PLoS One; 2018; 13(8):e0202954. PubMed ID: 30157279
[TBL] [Abstract][Full Text] [Related]
2. Naturally occurring autoantibodies against Aβ oligomers exhibited more beneficial effects in the treatment of mouse model of Alzheimer's disease than intravenous immunoglobulin.
Wang T; Xie XX; Ji M; Wang SW; Zha J; Zhou WW; Yu XL; Wei C; Ma S; Xi ZY; Pang GL; Liu RT
Neuropharmacology; 2016 Jun; 105():561-576. PubMed ID: 26907803
[TBL] [Abstract][Full Text] [Related]
3. Naturally Occurring Autoantibodies against Tau Protein Are Reduced in Parkinson's Disease Dementia.
Kronimus Y; Albus A; Balzer-Geldsetzer M; Straub S; Semler E; Otto M; Klotsche J; Dodel R; ; Mengel D
PLoS One; 2016; 11(11):e0164953. PubMed ID: 27802290
[TBL] [Abstract][Full Text] [Related]
4. Effect of Different Aβ Aggregates as Antigen on the Measure of Naturally Occurring Autoantibodies against Amyloid-β40/42 in IVIG.
Cao H; Du X; Zeng R; Lv Z; Ye S; Jiang P; Wang Z; Ma L; Huang Y; Li C; Zhang R; Liu F
Curr Alzheimer Res; 2019; 16(14):1290-1299. PubMed ID: 31894747
[TBL] [Abstract][Full Text] [Related]
5. Prion peptide uptake in microglial cells--the effect of naturally occurring autoantibodies against prion protein.
Roettger Y; Zerr I; Dodel R; Bach JP
PLoS One; 2013; 8(6):e67743. PubMed ID: 23840767
[TBL] [Abstract][Full Text] [Related]
6. Effect of naturally occurring α-synuclein-antibodies on toxic α-synuclein-fragments.
Rabenstein M; Besong Agbo D; Wolf E; Dams J; Nicolai M; Roeder A; Bacher M; Dodel RC; Noelker C
Neurosci Lett; 2019 Jun; 704():181-188. PubMed ID: 30954607
[TBL] [Abstract][Full Text] [Related]
7. Encoding the Sequence of Specific Autoantibodies Against beta-Amyloid and alpha-Synuclein in Neurodegenerative Diseases.
Albus A; Jördens M; Möller M; Dodel R
Front Immunol; 2019; 10():2033. PubMed ID: 31507618
[TBL] [Abstract][Full Text] [Related]
8. Synthetic dimeric Aβ(28-40) mimics the complex epitope of human anti-Aβ autoantibodies against toxic Aβ oligomers.
Roeder AM; Roettger Y; Stündel A; Dodel R; Geyer A
J Biol Chem; 2013 Sep; 288(38):27638-27645. PubMed ID: 23846683
[TBL] [Abstract][Full Text] [Related]
9. Naturally occurring autoantibodies against α-synuclein rescues memory and motor deficits and attenuates α-synuclein pathology in mouse model of Parkinson's disease.
Huang YR; Xie XX; Ji M; Yu XL; Zhu J; Zhang LX; Liu XG; Wei C; Li G; Liu RT
Neurobiol Dis; 2019 Apr; 124():202-217. PubMed ID: 30481547
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune antibody decline in Parkinson's disease and Multiple System Atrophy; a step towards immunotherapeutic strategies.
Brudek T; Winge K; Folke J; Christensen S; Fog K; Pakkenberg B; Pedersen LØ
Mol Neurodegener; 2017 Jun; 12(1):44. PubMed ID: 28592329
[TBL] [Abstract][Full Text] [Related]
11. Naturally occurring autoantibodies against beta-amyloid: investigating their role in transgenic animal and in vitro models of Alzheimer's disease.
Dodel R; Balakrishnan K; Keyvani K; Deuster O; Neff F; Andrei-Selmer LC; Röskam S; Stüer C; Al-Abed Y; Noelker C; Balzer-Geldsetzer M; Oertel W; Du Y; Bacher M
J Neurosci; 2011 Apr; 31(15):5847-54. PubMed ID: 21490226
[TBL] [Abstract][Full Text] [Related]
12. Comparison of intravenous immunoglobulins for naturally occurring autoantibodies against amyloid-beta.
Balakrishnan K; Andrei-Selmer LC; Selmer T; Bacher M; Dodel R
J Alzheimers Dis; 2010; 20(1):135-43. PubMed ID: 20164596
[TBL] [Abstract][Full Text] [Related]
13. Naturally occurring alpha-synuclein autoantibodies in Parkinson's disease: sources of (error) variance in biomarker assays.
Heinzel S; Gold M; Deuschle C; Bernhard F; Maetzler W; Berg D; Dodel R
PLoS One; 2014; 9(12):e114566. PubMed ID: 25470145
[TBL] [Abstract][Full Text] [Related]
14. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
[TBL] [Abstract][Full Text] [Related]
15. The Avidity of Autoreactive Alpha-Synuclein Antibodies in Leucine-Rich Repeat Kinase 2 Mutation Carriers Is Not Altered Compared to Healthy Controls or Patients with Parkinson's Disease.
Albus A; Kronimus Y; Burg-Roderfeld M; van der Wurp H; Willbold D; Ziehm T; Dodel R; Ross JA
Biomolecules; 2023 Aug; 13(9):. PubMed ID: 37759704
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of action of naturally occurring antibodies against β-amyloid on microglia.
Gold M; Mengel D; Röskam S; Dodel R; Bach JP
J Neuroinflammation; 2013 Jan; 10():5. PubMed ID: 23317003
[TBL] [Abstract][Full Text] [Related]
17. Naturally occurring autoantibodies against β-Amyloid.
Bach JP; Dodel R
Adv Exp Med Biol; 2012; 750():91-9. PubMed ID: 22903668
[TBL] [Abstract][Full Text] [Related]
18. Naturally occurring α-synuclein autoantibody levels are lower in patients with Parkinson disease.
Besong-Agbo D; Wolf E; Jessen F; Oechsner M; Hametner E; Poewe W; Reindl M; Oertel WH; Noelker C; Bacher M; Dodel R
Neurology; 2013 Jan; 80(2):169-75. PubMed ID: 23255825
[TBL] [Abstract][Full Text] [Related]
19. An 11-mer Amyloid Beta Peptide Fragment Provokes Chemical Mutations and Parkinsonian Biomarker Aggregation in Dopaminergic Cells: A Novel Road Map for "Transfected" Parkinson's.
Kabiraj P; Marin JE; Varela-Ramirez A; Narayan M
ACS Chem Neurosci; 2016 Nov; 7(11):1519-1530. PubMed ID: 27635664
[TBL] [Abstract][Full Text] [Related]
20. Distinct Autoimmune Anti-α-Synuclein Antibody Patterns in Multiple System Atrophy and Parkinson's Disease.
Folke J; Rydbirk R; Løkkegaard A; Salvesen L; Hejl AM; Starhof C; Bech S; Winge K; Christensen S; Pedersen LØ; Aznar S; Pakkenberg B; Brudek T
Front Immunol; 2019; 10():2253. PubMed ID: 31616427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
